Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000011

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 24, 2017
Accepted (ET)
Mar 2, 2017 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 24, 2017P500$0.031A19,666,349D
Common StockJan 24, 2017P500$0.0317A19,666,849D
Common StockJan 24, 2017P500$0.0299A19,667,349D
Common StockJan 24, 2017P500$0.0297A19,667,849D
Common StockJan 24, 2017P5,000$0.0297A19,672,849D
Common StockJan 24, 2017P3,000$0.0297A19,675,849D
Common StockJan 24, 2017P500$0.03A19,676,349D
Common StockJan 24, 2017P5,000$0.03A19,681,349D
Common StockJan 25, 2017P500$0.0274A19,681,849D
Common StockJan 25, 2017P500$0.0304A19,682,349D
Common StockJan 25, 2017P1,000$0.0302A19,683,349D
Common StockJan 25, 2017P1,000$0.0328A19,684,349D
Common StockJan 25, 2017P1,000$0.0375A19,685,349D
Common StockJan 25, 2017P1,000$0.05A19,686,349D
Common StockJan 25, 2017P1,000$0.0499A19,687,349D
Common StockJan 25, 2017P1,000$0.0498A19,688,349D
Common StockJan 25, 2017P500$0.035A19,688,849D
Common StockJan 25, 2017P500$0.035A19,689,349D
Common StockJan 25, 2017P1,000$0.035A19,690,349D
Common StockJan 25, 2017P500$0.035A19,690,849D
Common StockJan 26, 2017P500$0.0349A19,691,349D
Common StockJan 26, 2017P250$0.034A19,691,599D
Common StockJan 26, 2017P250$0.0349A19,691,849D
Common StockJan 26, 2017P500$0.0347A19,692,349D
Common StockJan 26, 2017P1,000$0.0348A19,693,349D
Common StockJan 26, 2017P1,000$0.0344A19,694,349D
Common StockJan 27, 2017P500$0.0347A19,694,849D
Common StockJan 27, 2017P200$0.0348A19,695,049D
Common StockJan 27, 2017P1,000$0.0345A19,696,049D
Common StockJan 27, 2017P200$0.0395A19,696,249D

Table II — derivative securities

No Table II lines on this filing.